CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer

CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer

As an important member of T cytotoxic pathway-related genes, CD8a molecule (CD8A) may be a useful biomarker of immunotherapeutic response and immune cell infiltration. We aimed to investigate the clinical predictive value of CD8A in prognosis and tumor microenvironment (TME) and preoperatively predi...

Full description

Bibliographic Details
Main Authors: Zongtai Zheng, Yadong Guo, Xiongsheng Huang, Ji Liu, Ruiliang Wang, Xiaofu Qiu, Shenghua Liu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
bladder cancer
CD8A
MRI
radiogenomics
immunotherapy
prognosis
Online Access:https://www.mdpi.com/2072-6694/14/19/4866

Internet

https://www.mdpi.com/2072-6694/14/19/4866

Similar Items